- Reliq Health Technologies’ (RHT) iUGO Care platform will go live in two clinical trials this month involving over 1,000 patients
- The trials are expected to generate average revenue of $40 per patient per month
- Reliq has also signed four new contracts with clients in Texas and Florida adding over 2,000 patients to Reliq’s iUGO Care platform in 2022
- The contracts will generate an average revenue of over $60 per patient per month
- Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring
- Reliq Health Technologies Inc. (RHT) opened trading at C$0.58 per share
Reliq Health Technologies (RHT) announced that its iUGO Care platform will go live in two clinical trials this month involving over 1,000 patients.
Reliq has also signed four new contracts with clients in Texas and Florida that are expected to add over 2,000 patients to Reliq’s iUGO Care platform in 2022.
Dr. Lisa Crossley, CEO at Reliq Health Technologies commented on the news.
“We are very pleased to be going live in our first clinical trials this month. Our Clinical Research Organization (CRO) client will be using Reliq’s iUGO Care platform to monitor patients in two separate clinical trials focused on hypertension and oncology, respectively. Using iUGO Care for clinical trials allows CROs and trial sponsors to monitor trial-specific metrics such as medication adherence, side effects, safety issues and efficacy. These two trials are expected to add at least 1,000 patients to the iUGO Care platform this year and generate average revenue of $40 per patient per month at a gross margin of 75 per cent.
The company has also signed four new contracts with two physician practices and two home health agencies that are expected to onboard over 2,000 new patients in Texas and Florida to Reliq’s iUGO Care platform in 2022. Onboarding will begin next month and is expected to be completed by the end of the calendar year. The contracts are expected to generate an average revenue of over $60 per patient per month at 75 per cent gross margin.”
Reliq Health Technologies specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.
Reliq Health Technologies Inc. (RHT) opened trading at C$0.58 per share.
